Amir Nashat's Net Worth
$310 Thousand
Who is Amir Nashat?
Amir Nashat does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Morphic Holding, Inc., BIND Therapeutics, Inc, Receptos, Inc., Scholar Rock Holding Corp, FATE THERAPEUTICS INC, SELECTA BIOSCIENCES INC, Metacrine, Inc., Syros Pharmaceuticals, Inc., and aTYR PHARMA INC.
SEC CIK
Amir Nashat's CIK is 0001575843
Past Insider Trading and Trends
2021 was Amir Nashat's most active year for acquiring shares with 7 total transactions. Amir Nashat's most active month to acquire stocks was the month of May. 2024 was Amir Nashat's most active year for disposing of shares, totalling 7 transactions. Amir Nashat's most active month to dispose stocks was the month of July. 2023 saw Amir Nashat paying a total of $0.00 for 88,078 shares, this is the most they've acquired in one year. In 2024 Amir Nashat cashed out on 99,308 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Morphic Holding, Inc. (MORF) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.99M |
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| -4.78% | -99.86K |
—
|
—
| 1.99M |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -10.00% | -232.29K |
$45.50 | -$10,569,422.50 | 2.09M |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 2.32M |
$15.00 |
—
| 2.32M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4/A
| -41.12% | -19.26K |
—
|
—
| 27.59K |
May 27
| |||
Form 4
| -49.25% | -379.27K |
—
|
—
| 390.82K |
May 27
| |||
Form 4
| -17.22% | -170.00K |
$26.70 | -$4,538,860.00 | 816.94K |
Dec 6
| |||
Form 4/A
| -7.63% | -169.31K |
$24.77 | -$4,225,871.04 | 2.05M |
Nov 14 - Nov 15
| |||
Form 4
| -3.02% | -30.68K |
$22.77 | -$698,697.45 | 986.94K |
Nov 20
| |||
Form 4/A
| -14.26% | -169.31K |
$24.96 | -$4,225,871.04 | 1.02M |
Nov 14 - Nov 15
| |||
Form 4
| -14.28% | -169.31K |
$24.96 | -$4,225,871.04 | 1.02M |
Nov 14 - Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
∞
| 1.19M |
$8.53 | $10,123,966.81 | 1.19M |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Scholar Rock Holding Corp (SRRK) Snapshot price: $8.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -21.40% | -486.55K |
—
|
—
| 1.79M |
May 9
| |||
Form 4
| -45.55% | -21.33K |
—
|
—
| 25.51K |
Dec 27
| |||
Form 4
| -29.77% | -973.09K |
—
|
—
| 2.3M |
Dec 13
| |||
Form 4
| -12.96% | -486.55K |
—
|
—
| 3.27M |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +46.99% | 1.2M |
$4.90 | $5,870,160.80 | 3.75M |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| -9.73% | -275.65K |
—
|
—
| 2.56M |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 2.83M |
$14.00 |
—
| 2.83M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.16% | -62.01K |
$22.53 | -$1,397,066.29 | 1.14M |
Scheduled
|
Jul 31 - Aug 1
| ||
Form 4
| -8.96% | -118.33K |
$22.51 | -$2,663,114.73 | 1.2M |
Scheduled
|
Jul 26 - Jul 30
| ||
Form 4
| -5.84% | -81.90K |
$22.51 | -$1,843,150.96 | 1.32M |
Scheduled
|
Jul 23 - Jul 24
| ||
Form 4
| -4.83% | -71.17K |
$22.52 | -$1,602,505.66 | 1.4M |
Scheduled
|
Jul 18 - Jul 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| -3.47% | -53.02K |
$14.16 | -$750,959.30 | 1.47M |
Jan 30
| |||
Form 4
| -6.00% | -97.50K |
$14.16 | -$1,380,795.18 | 1.53M |
Jan 29
| |||
Form 4
| -4.13% | -70.00K |
$13.78 | -$964,768.00 | 1.62M |
Jan 28
| |||
Form 4
| -5.05% | -90.00K |
$14.14 | -$1,272,753.00 | 1.69M |
Jan 25
| |||
Form 4
| -2.17% | -39.48K |
$16.28 | -$642,834.38 | 1.78M |
Jan 18
| |||
Form 4
| -1.80% | -33.47K |
$12.25 | -$410,160.27 | 1.82M |
Dec 20
| |||
Form 4
| -4.68% | -91.21K |
$13.40 | -$1,222,592.34 | 1.86M |
Dec 19
| |||
Form 4
| -0.90% | -17.79K |
$16.67 | -$296,563.31 | 1.95M |
Dec 13
| |||
Form 4
| -17.78% | -425.00K |
$16.78 | -$7,132,690.00 | 1.97M |
Dec 12
| |||
Form 4
| -3.34% | -82.53K |
$16.71 | -$1,379,183.18 | 2.39M |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +12.44% | 2.47M |
$6.00 | $5,770,674.00 | 22.35M |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||